Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT
Leopold Sellner(National Center for Tumor Diseases), Ariane Boumendil(Inserm), Eliana Zuffa(Ospedale "Santa Maria delle Croci" di Ravenna), Emmanuelle Nicolas‐Virelizier(Hôpital Edouard Herriot), Sylvain Choquet(Sorbonne Université), Gaetano De Rosa(University of Naples Federico II), Edgar Faber(University Hospital Olomouc), Jürgen Finke(University Medical Center Freiburg), Luca Facchini(Azienda Sanitaria Unità Locale di Reggio Emilia), Felicetto Ferrara(San Antonio College), Daniele Vallisa(Ospedaliera di Piacenza), Ibrahim Yakoub‐Agha(Inserm), Franca Falzetti(University of Perugia), Hervé Finel, Alain Delmer(Centre Hospitalier Universitaire de Reims), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Peter Dreger(Heidelberg University), Gilles Salles(Memorial Sloan Kettering Cancer Center), Rosanna Scimè(La Maddalena), S. Amorim(Hôpital Saint-Vincent-de-Paul), Herbert G. Sayer(Friedrich Schiller University Jena), Guido Kobbe(Düsseldorf University Hospital), Réda Bouabdallah(Institut Paoli-Calmettes)
Cited by 49
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k